These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11137234)

  • 21. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.
    Toussaint JF; Rziha HJ; Bauer B; Letellier C; Kerkhofs P
    Vet Rec; 2004 Oct; 155(18):553-8. PubMed ID: 15559987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
    Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
    Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field.
    Mars MH; de Jong MC; Franken P; van Oirschot JT
    Vaccine; 2001 Feb; 19(15-16):1924-30. PubMed ID: 11228362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD.
    Gogev S; Vanderheijden N; Lemaire M; Schynts F; D'Offay J; Deprez I; Adam M; Eloit M; Thiry E
    Vaccine; 2002 Jan; 20(9-10):1451-65. PubMed ID: 11818166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV.
    Schrijver RS; Langedijk JP; Keil GM; Middel WG; Maris-Veldhuis M; Van Oirschot JT; Rijsewijk FA
    Vaccine; 1997 Dec; 15(17-18):1908-16. PubMed ID: 9413101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves.
    van Engelenburg FA; Kaashoek MJ; Rijsewijk FA; van den Burg L; Moerman A; Gielkens AL; van Oirschot JT
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2311-8. PubMed ID: 8077929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine.
    Bosch JC; Kaashoek MJ; van Oirschot JT
    Vaccine; 1997 Oct; 15(14):1512-7. PubMed ID: 9330461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction, characterization and immunogenicity of a glycoprotein E negative bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad".
    El-Kholy AA; Rady DI; Abdou ER; Elseafy MM; Abdelrahman KA; Soliman H
    J Virol Methods; 2013 Dec; 194(1-2):74-81. PubMed ID: 23962750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
    Kalthoff D; König P; Trapp S; Beer M
    Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154.
    Manoj S; Griebel PJ; Babiuk LA; van Drunen Littel-van den Hurk S
    Immunology; 2004 Jun; 112(2):328-38. PubMed ID: 15147576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle.
    Zheng C; Babiuk LA; van Drunen Littel-van den Hurk S
    J Virol; 2005 Feb; 79(3):1948-53. PubMed ID: 15650221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1.
    Toussaint JF; Letellier C; Paquet D; Dispas M; Kerkhofs P
    Vaccine; 2005 Oct; 23(43):5073-81. PubMed ID: 16024138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
    Patel JR; Shilleto RW
    Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strains of bovine herpesvirus 1 that do not express an epitope on glycoprotein E in cell culture still induce antibodies that can be detected in a gE-blocking ELISA.
    van Oirschot JT; Kaashoek MJ; Maris-Veldhuis MA; Rijsewijk FA
    Vet Microbiol; 1999 Mar; 65(2):103-13. PubMed ID: 10078594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine.
    Belknap EB; Walters LM; Kelling C; Ayers VK; Norris J; McMillen J; Hayhow C; Cochran M; Reddy DN; Wright J; Collins JK
    Vaccine; 1999 May; 17(18):2297-305. PubMed ID: 10403598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies against bovine herpesvirus (BHV) 5 may be differentiated from antibodies against BHV1 in a BHV1 glycoprotein E blocking ELISA.
    Wellenberg GJ; Mars MH; Van Oirschot JT
    Vet Microbiol; 2001 Jan; 78(1):79-84. PubMed ID: 11118743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies.
    van Drunen Littel-van den Hurk S; Snider M; Thompson P; Latimer L; Babiuk LA
    Vaccine; 2008 Jun; 26(25):3103-11. PubMed ID: 18433948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field.
    Dispas M; Schynts F; Lemaire M; Letellier C; Vanopdenbosch E; Thiry E; Kerkhofs P
    Vet Rec; 2003 Aug; 153(7):209-12. PubMed ID: 12956298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.